|
|
|
|
|
|
|
|
|
Long-term follow-up data suggests arthroscopic partial meniscectomy provides no clinical benefits, and may even cause harm. |
 |
|
The FIDELITY Trial was one of the first major orthopaedic RCTs that called into question the usefulness of arthroscopic partial meniscectomy for meniscal tears.
But there were always question marks as to whether the results would hold out in the long-term. Fortunately, the 10-year results are in.
No benefit vs. sham surgery in all outcomes. And in some outcomes, there was even evidence of inferiority with arthroscopic partial meniscectomy.
It's a major indictment on its use in middle-aged and older adults. And its valuable information for you when making your next clinical decision. |
|
|
|
Full Analysis → |
|
|
|
|
|
|
|
|
|
|
|
Randomized trial of 1900 patients finds no reduction in infection or wound complications with vancomycin powder, povidone-iodine lavage, or both in high-risk TJA cases. |
 |
|
If there's one thing every arthroplasty surgeon wants to avoid, it's periprosthetic joint infection.
Vancomycin powder use and dilute povidone-iodine lavage are high-prevalence strategies seen in thousands of operating rooms, but do they actually work?
In an RCT of 1,900 high-risk total joint patients, the evidence was clear: there were no reductions in wound complications or 3-month infection rates with either strategy, or both combined, vs placebo.
Long-term follow-up studies are certainly required, but the short-term evidence indicates that the decision can be considered a discretionary one. |
|
|
|
Full Analysis → |
|
|
|
|
|
|
|
|
|
Two ways to inform your clinical decisions |
FastTrack — what your peers are reading across the network
OE Signal — personalized weekly evidence based on your interests |
|
|
|
|